Researchers have developed a method to make adaptive and eco-friendly sensors that can be directly and imperceptibly printed onto a wide range of biological surfaces, whether that’s a finger or a flower petal.
Co-founder and CEO of Start Codon, Jason Mellad on helping healthcare start-ups thrive and why inclusion and diversity will change the world.
Biotech firms have developed nearly 40% more of key treatments for unmet medical needs, says a new book co-authored by Cambridge researchers.
Meet the young biotech entrepreneur with two companies to her name and a plan to revolutionise the way we manage our health.
We spoke with Cambridge’s most recent Nobel Laureate about decades of research, spin-outs, pharma giants and the booming life sciences cluster in Greater Cambridge.
Researchers have developed a three-dimensional ‘organ on a chip’ which enables real-time continuous monitoring of cells, and could be used to develop new treatments for disease while reducing the number of animals used in research.
Researchers have successfully demonstrated how an electronic device implanted directly into the brain can detect, stop and even prevent epileptic seizures.
An international team of researchers have developed a low-cost sensor made from semiconducting plastic that can be used to diagnose or monitor a wide range of health conditions, such as surgical complications or neurodegenerative diseases.
“I was taught that the way of progress is neither swift nor easy”.
Human genome editing, 3D-printed replacement organs and artificial photosynthesis – the field of bioengineering offers great promise for tackling the major challenges that face our society. But as a new article out today highlights, these developments provide both opportunities and risks in the short and long term.
© 2024 University of Cambridge